Skip to main content
. Author manuscript; available in PMC: 2021 Nov 21.
Published in final edited form as: Cancer. 2021 Apr 21;127(17):3194–3201. doi: 10.1002/cncr.33591

TABLE 3.

Best Response Summary by Version 1.1 of RECIST (n = 19)

Best RECIST Response No. (%)
Confirmed partial response 5 (26)
Clinical benefit (stable disease for ≥6 mo) 1 (5)
Stable disease for <6 mo 5 (26)
Progression 7 (37)
Not assesseda 1 (5)

Abbreviation: RECIST, Response Evaluation Criteria in Solid Tumors.

a

The patient received palliative radiation therapy before the first scan and was not assessable for a RECIST response.